Seeing Is Believing
ALNY is currently covered by 26 analysts with an average price target of $271.07. This is a potential upside of $36.23 (15.43%) from yesterday's end of day stock price of $234.84.
Alnylam Pharmaceuticals's activity chart (see below) currently has 346 price targets and 352 ratings on display. The stock rating distribution of ALNY is 31.3% HOLD and 68.7% BUY.
Analysts average stock forecasts to be materialized ratio is 84.27% with an average time for these price targets to be met of 234.38 days.
Highest price target for ALNY is $400, Lowest price target is $170, average price target is $271.07.
Most recent stock forecast was given by MICHAEL ULZ from MORGAN STANLEY on 12-Jul-2024.
Currently out of the existing stock ratings of ALNY, 36 are a HOLD (31.3%), 79 are a BUY (68.7%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
255
$17.17 (7.22%)
250
14 days ago
8/8 (100%)
$-5.51 (-2.12%)
41
Buy
357
$119.17 (50.11%)
283
18 days ago
1/7 (14.29%)
$101.89 (39.94%)
338
Buy
295
$57.17 (24.04%)
240
29 days ago
16/17 (94.12%)
$48 (19.43%)
255
Buy
265
$27.17 (11.42%)
250
29 days ago
8/16 (50%)
$18 (7.29%)
214
Hold
207
$-30.83 (-12.96%)
161
1 months 1 days ago
2/3 (66.67%)
$-33.15 (-13.80%)
5
What is ALNY (Alnylam Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on ALNY (Alnylam Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on ALNY (Alnylam Pharmaceuticals)?
Which analyst is the currently most bullish on ALNY (Alnylam Pharmaceuticals)?
Which analyst is the currently most reserved on ALNY (Alnylam Pharmaceuticals)?